GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 19.33
(1.52%)
CNY 19.33
(1.52%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 114.81 Million CNY | 133.7% |
| 2022 | -340.67 Million CNY | 8.56% |
| 2021 | -372.55 Million CNY | -442.22% |
| 2020 | 108.86 Million CNY | -54.91% |
| 2019 | 241.45 Million CNY | -47.3% |
| 2018 | 458.18 Million CNY | 63.7% |
| 2017 | 279.88 Million CNY | 56.29% |
| 2016 | 179.08 Million CNY | 1047.1% |
| 2015 | 15.61 Million CNY | 388.27% |
| 2014 | -5.41 Million CNY | 91.77% |
| 2013 | -65.81 Million CNY | 59.81% |
| 2012 | -163.74 Million CNY | -209.43% |
| 2011 | -52.91 Million CNY | 56.49% |
| 2010 | -121.63 Million CNY | 21.26% |
| 2009 | -154.47 Million CNY | 55.64% |
| 2008 | -348.2 Million CNY | -593.28% |
| 2007 | -50.22 Million CNY | -170.11% |
| 2006 | 71.63 Million CNY | 21.38% |
| 2005 | 59.01 Million CNY | 46.43% |
| 2004 | 40.3 Million CNY | -29.66% |
| 2003 | 57.29 Million CNY | 9.0% |
| 2002 | 52.56 Million CNY | 14.07% |
| 2001 | 46.07 Million CNY | -17.39% |
| 2000 | 55.77 Million CNY | 71.95% |
| 1999 | 32.43 Million CNY | 143.98% |
| 1998 | 13.29 Million CNY | -10.14% |
| 1997 | 14.79 Million CNY | 11.92% |
| 1996 | 13.21 Million CNY | -13.54% |
| 1995 | 15.29 Million CNY | 225.69% |
| 1994 | 4.69 Million CNY | 22.57% |
| 1993 | 3.83 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 6.5 Million CNY | -89.54% |
| 2024 Q1 | 62.23 Million CNY | 235.12% |
| 2024 Q3 | 16.17 Million CNY | 148.51% |
| 2023 Q4 | 18.56 Million CNY | 274.38% |
| 2023 Q1 | 16.01 Million CNY | 104.18% |
| 2023 FY | 114.81 Million CNY | 133.7% |
| 2023 Q2 | 5.42 Million CNY | -66.11% |
| 2023 Q3 | 4.96 Million CNY | -8.64% |
| 2022 Q3 | -48.36 Million CNY | -394.36% |
| 2022 Q2 | -9.78 Million CNY | -184.24% |
| 2022 Q1 | 11.61 Million CNY | 104.96% |
| 2022 Q4 | -382.87 Million CNY | -691.59% |
| 2022 FY | -340.67 Million CNY | 8.56% |
| 2021 Q4 | -234.34 Million CNY | -212.32% |
| 2021 Q1 | 7.32 Million CNY | 114.8% |
| 2021 Q3 | -75.03 Million CNY | -9.45% |
| 2021 FY | -372.55 Million CNY | -442.22% |
| 2021 Q2 | -68.55 Million CNY | -1035.43% |
| 2020 Q3 | 21.81 Million CNY | 1313.43% |
| 2020 FY | 108.86 Million CNY | -54.91% |
| 2020 Q1 | 29.2 Million CNY | 152.31% |
| 2020 Q2 | -1.79 Million CNY | -106.16% |
| 2020 Q4 | -49.52 Million CNY | -326.99% |
| 2019 FY | 241.45 Million CNY | -47.3% |
| 2019 Q1 | 52.22 Million CNY | -70.57% |
| 2019 Q2 | 73.06 Million CNY | 39.9% |
| 2019 Q4 | -55.83 Million CNY | -178.79% |
| 2019 Q3 | 70.86 Million CNY | -3.02% |
| 2018 Q4 | 177.45 Million CNY | 75.09% |
| 2018 Q2 | 111.14 Million CNY | 62.88% |
| 2018 FY | 458.18 Million CNY | 63.7% |
| 2018 Q1 | 68.23 Million CNY | -52.28% |
| 2018 Q3 | 101.34 Million CNY | -8.81% |
| 2017 FY | 279.88 Million CNY | 56.29% |
| 2017 Q4 | 142.99 Million CNY | 327.71% |
| 2017 Q3 | 33.43 Million CNY | -50.81% |
| 2017 Q2 | 67.96 Million CNY | 91.52% |
| 2017 Q1 | 35.48 Million CNY | -51.16% |
| 2016 Q3 | 43.3 Million CNY | 22.89% |
| 2016 Q2 | 35.23 Million CNY | 26.42% |
| 2016 Q4 | 72.66 Million CNY | 67.78% |
| 2016 Q1 | 27.87 Million CNY | 124.23% |
| 2016 FY | 179.08 Million CNY | 1047.1% |
| 2015 FY | 15.61 Million CNY | 388.27% |
| 2015 Q2 | 8.32 Million CNY | 674.49% |
| 2015 Q4 | 12.43 Million CNY | 436.14% |
| 2015 Q3 | -3.69 Million CNY | -144.41% |
| 2015 Q1 | -1.44 Million CNY | 91.19% |
| 2014 Q2 | 21.48 Million CNY | 293.71% |
| 2014 Q1 | -11.09 Million CNY | 64.61% |
| 2014 FY | -5.41 Million CNY | 91.77% |
| 2014 Q4 | -16.45 Million CNY | -2657.83% |
| 2014 Q3 | 643.18 Thousand CNY | -97.01% |
| 2013 Q4 | -31.34 Million CNY | -150.4% |
| 2013 FY | -65.81 Million CNY | 59.81% |
| 2013 Q3 | -12.51 Million CNY | 50.99% |
| 2013 Q2 | -25.53 Million CNY | -813.18% |
| 2013 Q1 | 3.58 Million CNY | 103.72% |
| 2012 FY | -163.74 Million CNY | -209.43% |
| 2012 Q2 | -35.8 Million CNY | -121.46% |
| 2012 Q3 | -15.59 Million CNY | 56.44% |
| 2012 Q4 | -96.17 Million CNY | -516.6% |
| 2012 Q1 | -16.16 Million CNY | -156.89% |
| 2011 Q2 | -30.83 Million CNY | -13.19% |
| 2011 Q1 | -27.24 Million CNY | 45.42% |
| 2011 Q3 | -23.25 Million CNY | 24.58% |
| 2011 Q4 | 28.41 Million CNY | 222.2% |
| 2011 FY | -52.91 Million CNY | 56.49% |
| 2010 Q1 | -20.76 Million CNY | 60.65% |
| 2010 Q2 | -24.22 Million CNY | -16.66% |
| 2010 Q3 | -26.73 Million CNY | -10.38% |
| 2010 Q4 | -49.91 Million CNY | -86.71% |
| 2010 FY | -121.63 Million CNY | 21.26% |
| 2009 FY | -154.47 Million CNY | 55.64% |
| 2009 Q1 | -18.91 Million CNY | 93.03% |
| 2009 Q2 | -44.92 Million CNY | -137.47% |
| 2009 Q3 | -37.86 Million CNY | 15.72% |
| 2009 Q4 | -52.76 Million CNY | -39.36% |
| 2008 Q3 | -101.62 Million CNY | -1937.81% |
| 2008 Q4 | -271.41 Million CNY | -167.09% |
| 2008 Q2 | 5.52 Million CNY | -71.36% |
| 2008 Q1 | 19.3 Million CNY | 123.98% |
| 2008 FY | -348.2 Million CNY | -593.28% |
| 2007 FY | -50.22 Million CNY | -170.11% |
| 2007 Q2 | 8.98 Million CNY | -53.71% |
| 2007 Q1 | 19.4 Million CNY | 48306.63% |
| 2007 Q3 | 1.91 Million CNY | -78.74% |
| 2007 Q4 | -80.52 Million CNY | -4315.02% |
| 2006 Q1 | 29.77 Million CNY | 83.35% |
| 2006 Q4 | -40.26 Thousand CNY | -100.42% |
| 2006 Q3 | 9.56 Million CNY | -70.41% |
| 2006 Q2 | 32.32 Million CNY | 8.56% |
| 2006 FY | 71.63 Million CNY | 21.38% |
| 2005 Q2 | 7.71 Million CNY | -64.97% |
| 2005 FY | 59.01 Million CNY | 46.43% |
| 2005 Q1 | 22.02 Million CNY | 268.23% |
| 2005 Q3 | 13.03 Million CNY | 68.87% |
| 2005 Q4 | 16.24 Million CNY | 24.64% |
| 2004 Q2 | 16 Million CNY | -30.58% |
| 2004 Q1 | 23.05 Million CNY | 79.6% |
| 2004 FY | 40.3 Million CNY | -29.66% |
| 2004 Q4 | -13.09 Million CNY | -191.32% |
| 2004 Q3 | 14.33 Million CNY | -10.42% |
| 2003 Q2 | 12.58 Million CNY | -41.48% |
| 2003 FY | 57.29 Million CNY | 9.0% |
| 2003 Q1 | 21.5 Million CNY | -30.51% |
| 2003 Q4 | 12.83 Million CNY | 23.94% |
| 2003 Q3 | 10.35 Million CNY | -17.72% |
| 2002 Q2 | 10.41 Million CNY | 268.12% |
| 2002 FY | 52.56 Million CNY | 14.07% |
| 2002 Q3 | 8.36 Million CNY | -19.68% |
| 2002 Q4 | 30.95 Million CNY | 270.0% |
| 2002 Q1 | 2.82 Million CNY | 0.0% |
| 2001 FY | 46.07 Million CNY | -17.39% |
| 2000 FY | 55.77 Million CNY | 71.95% |
| 1999 FY | 32.43 Million CNY | 143.98% |
| 1998 FY | 13.29 Million CNY | -10.14% |
| 1997 FY | 14.79 Million CNY | 11.92% |
| 1996 FY | 13.21 Million CNY | -13.54% |
| 1995 FY | 15.29 Million CNY | 225.69% |
| 1994 FY | 4.69 Million CNY | 22.57% |
| 1993 FY | 3.83 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.9 Billion CNY | 97.662% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.39 Billion CNY | 96.617% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 788.26 Million CNY | 85.435% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 82.83 Million CNY | -38.597% |
| Aurora Optoelectronics Co.,Ltd. | -505.31 Million CNY | 122.721% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -37.56 Million CNY | 405.601% |
| NanJing Pharmaceutical Company Limited | 1.49 Billion CNY | 92.306% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.36 Billion CNY | 91.589% |